{"tid":2130567,"cid":5,"subCid":10,"title":"［希望］袁國勇參與研究 發現 21 種現有藥可阻武肺病毒複製 增患者治療選項","createTime":"2020-07-29T09:37:54.000Z","updateTime":"2020-07-29T16:23:32.000Z","uid":48083,"like":3,"dislike":0,"uniUserReply":5,"replies":[{"pid":"bffe05b6d17de11912fa4bf2dd83d7954f888824","tid":2130567,"uid":48083,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-07-29T09:37:54.000Z","msg":"要開發一種藥物可能需要花費數億元和數以十年計的時間，尤其現時武漢肺炎 (COVID-19) 大流行未有特效藥下醫治不斷累積的感染者，很多學者都試圖尋找現有藥物能否有治療 COVID-19 的功效。最新刊於《自然》的研究指，找到 21 種已開發藥物可能成為潛在 COVID-19 療法。<br />\n<br />\n團隊在報告中明言：「開發疫苗可能需要至少 12&ndash;18 個月，批准新抗病毒治療藥物的典型時間表可能超過 10 年。因此，重新利用已知藥物可大大加快 COVID-19 新型療法的部署。」<br />\n<br />\n該團隊由美國、香港與奧地利學者聯合組成，港大學者包括微生物學系講座教授袁國勇亦有參與其中。<br />\n<br />\n<a href=\"http://thestandnews.com/cosmos/%E8%A2%81%E5%9C%8B%E5%8B%87%E5%8F%83%E8%88%87%E7%A0%94%E7%A9%B6-%E7%99%BC%E7%8F%BE-21-%E7%A8%AE%E7%8F%BE%E6%9C%89%E8%97%A5%E5%8F%AF%E9%98%BB%E6%AD%A6%E8%82%BA%E7%97%85%E6%AF%92%E8%A4%87%E8%A3%BD-%E5%A2%9E%E6%82%A3%E8%80%85%E6%B2%BB%E7%99%82%E9%81%B8%E9%A0%85/\" data-sr-url=\"https://r.lihkg.com/link?u=http%3A%2F%2Fthestandnews.com%2Fcosmos%2F%25E8%25A2%2581%25E5%259C%258B%25E5%258B%2587%25E5%258F%2583%25E8%2588%2587%25E7%25A0%2594%25E7%25A9%25B6-%25E7%2599%25BC%25E7%258F%25BE-21-%25E7%25A8%25AE%25E7%258F%25BE%25E6%259C%2589%25E8%2597%25A5%25E5%258F%25AF%25E9%2598%25BB%25E6%25AD%25A6%25E8%2582%25BA%25E7%2597%2585%25E6%25AF%2592%25E8%25A4%2587%25E8%25A3%25BD-%25E5%25A2%259E%25E6%2582%25A3%25E8%2580%2585%25E6%25B2%25BB%25E7%2599%2582%25E9%2581%25B8%25E9%25A0%2585%2F&d=SjiHudolEFiOjT3rBZQy6aGgm0NOSfkDZSs230CVm%2Fs%3D&h=a74366e8\" data-ef-url=\"https://embed.lih.kg/frame?u=http%3A%2F%2Fthestandnews.com%2Fcosmos%2F%25E8%25A2%2581%25E5%259C%258B%25E5%258B%2587%25E5%258F%2583%25E8%2588%2587%25E7%25A0%2594%25E7%25A9%25B6-%25E7%2599%25BC%25E7%258F%25BE-21-%25E7%25A8%25AE%25E7%258F%25BE%25E6%259C%2589%25E8%2597%25A5%25E5%258F%25AF%25E9%2598%25BB%25E6%25AD%25A6%25E8%2582%25BA%25E7%2597%2585%25E6%25AF%2592%25E8%25A4%2587%25E8%25A3%25BD-%25E5%25A2%259E%25E6%2582%25A3%25E8%2580%2585%25E6%25B2%25BB%25E7%2599%2582%25E9%2581%25B8%25E9%25A0%2585%2F&h=088f0c67\" target=\"_blank\">http://thestandnews.com/cosmos/%E8%A2%81%E5%9C%8B%E5%8B%87%E5%8F%83%E8%88%87%E7%A0%94%E7%A9%B6-%E7%99%BC%E7%8F%BE-21-%E7%A8%AE%E7%8F%BE%E6%9C%89%E8%97%A5%E5%8F%AF%E9%98%BB%E6%AD%A6%E8%82%BA%E7%97%85%E6%AF%92%E8%A4%87%E8%A3%BD-%E5%A2%9E%E6%82%A3%E8%80%85%E6%B2%BB%E7%99%82%E9%81%B8%E9%A0%85/</a><br />\n<br />\n<br />\n報告：<br />\n<a href=\"https://www.nature.com/articles/s41586-020-2577-1\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41586-020-2577-1&d=SjiHudolEFiOjT3rBZQy6aGgm0NOSfkDZSs230CVm%2Fs%3D&h=f3905d23\" target=\"_blank\">https://www.nature.com/articles/s41586-020-2577-1</a><br />\n<br />\nRiva, L., Yuan, S., Yin, X. &amp; et al. (2020). Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. doi: 10.1038/s41586-020-2577-1"},{"pid":"d1f4ca67b3328e2df6a432fe9b96be47a8223010","tid":2130567,"uid":3149,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-07-29T09:53:13.000Z","msg":"Push <img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/agree.gif\" class=\"hkgmoji\" />"},{"pid":"76585a48ad765f98c73710a6f128c88d9a4e05cd","tid":2130567,"uid":53026,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2020-07-29T09:53:29.000Z","msg":"仲有外國學者肯同香港合作研究？<img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" />"},{"pid":"eaf4350c88f75a09740ef0b8a633015b176a74ec","tid":2130567,"uid":56698,"like":1,"dislike":0,"score":1,"quote":{"pid":"76585a48ad765f98c73710a6f128c88d9a4e05cd","tid":2130567,"uid":53026,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2020-07-29T09:53:29.000Z","msg":"仲有外國學者肯同香港合作研究？<img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2020-07-29T09:56:17.000Z","msg":"可能喺最後一次，不過袁咁出名，真喺唔驚"},{"pid":"c275d265c86c9ea740a131bf54d98da48f057795","tid":2130567,"uid":109557,"like":0,"dislike":0,"score":0,"quote":{"pid":"76585a48ad765f98c73710a6f128c88d9a4e05cd","tid":2130567,"uid":53026,"like":1,"dislike":0,"score":1,"citedBy":2,"replyTime":"2020-07-29T09:53:29.000Z","msg":"仲有外國學者肯同香港合作研究？<img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/shocking.gif\" class=\"hkgmoji\" />"},"citedBy":0,"replyTime":"2020-07-29T16:23:32.000Z","msg":"勾結外國勢力<img src=\"/assets/faces/normal/@.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/@.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/normal/@.gif\" class=\"hkgmoji\" />"}]}